Jundishapur Journal of Microbiology

Published by: Kowsar

A Survey of gyrA Target-Site Mutation and qnr Genes among Clinical Isolates of Escherichia coli in the North of Iran

Setareh Yousefi 1 , Ali Mojtahedi 1 , 2 , * and Mohammad Shenagari 1 , 2
Authors Information
1 Department of Microbiology, Faculty of Medicine, Guilan University of Medical Sciences, Rasht, Iran
2 Molecular and Cellular Research Center, Faculty of Medicine, Guilan University of Medical Sciences, Rasht, Iran
Article information
  • Jundishapur Journal of Microbiology: September 2018, 11 (9); e67293
  • Published Online: August 20, 2018
  • Article Type: Research Article
  • Received: February 9, 2018
  • Revised: August 4, 2018
  • Accepted: August 5, 2018
  • DOI: 10.5812/jjm.67293

To Cite: Yousefi S , Mojtahedi A , Shenagari M . A Survey of gyrA Target-Site Mutation and qnr Genes among Clinical Isolates of Escherichia coli in the North of Iran, Jundishapur J Microbiol. 2018 ; 11(9):e67293. doi: 10.5812/jjm.67293.

Copyright © 2018, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
  • 1. Al-Badr A, Al-Shaikh G. Recurrent urinary tract infections management in women: a review. Sultan Qaboos Univ Med J. 2013;13(3):359-67. [PubMed: 23984019]. [PubMed Central: PMC3749018].
  • 2. Ebrahim-Saraie HS, Nezhad NZ, Heidari H, Motamedifar A, Motamedifar M. Detection of antimicrobial susceptibility and Integrons among extended-spectrum beta-lactamase producing uropathogenic Escherichia coli isolates in Southwestern Iran. Oman Med J. 2018;33(3):218-23. doi: 10.5001/omj.2018.40. [PubMed: 29896329]. [PubMed Central: PMC5971052].
  • 3. Asgharzadeh Kangachar S, Mojtahedi A. The presence of extended-spectrum β-lactamase as a risk factor for MDR in clinical isolation of Escherichia coli. Trop Biomed. 2017;34(1):98-109.
  • 4. Flores-Mireles AL, Walker JN, Caparon M, Hultgren SJ. Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nat Rev Microbiol. 2015;13(5):269-84. doi: 10.1038/nrmicro3432. [PubMed: 25853778]. [PubMed Central: PMC4457377].
  • 5. Bennett PM. Plasmid encoded antibiotic resistance: acquisition and transfer of antibiotic resistance genes in bacteria. Br J Pharmacol. 2008;153 Suppl 1:S347-57. doi: 10.1038/sj.bjp.0707607. [PubMed: 18193080]. [PubMed Central: PMC2268074].
  • 6. Malekzadegan Y, Hadadi M, Ebrahim-Saraie HS, Heidari H, Motamedifar M. Antimicrobial resistance pattern and frequency of multiple-drug resistant Enterobacter spp. at a tertiary care hospital in Southwest of Iran. J Krishna Inst Med Sci. 2017;6(2):33-9.
  • 7. Aldred KJ, Kerns RJ, Osheroff N. Mechanism of quinolone action and resistance. Biochemistry. 2014;53(10):1565-74. doi: 10.1021/bi5000564. [PubMed: 24576155]. [PubMed Central: PMC3985860].
  • 8. Heisig P. Genetic evidence for a role of parC mutations in development of high-level fluoroquinolone resistance in Escherichia coli. Antimicrob Agents Chemother. 1996;40(4):879-85. [PubMed: 8849244]. [PubMed Central: PMC163223].
  • 9. Fu Y, Zhang W, Wang H, Zhao S, Chen Y, Meng F, et al. Specific patterns of gyrA mutations determine the resistance difference to ciprofloxacin and levofloxacin in Klebsiella pneumoniae and Escherichia coli. BMC Infect Dis. 2013;13:8. doi: 10.1186/1471-2334-13-8. [PubMed: 23295059]. [PubMed Central: PMC3576228].
  • 10. Tayebi Z, Heidari H, Kazemian H, Ghafoori SM, Boroumandi S, Houri H. Comparison of quinolone and beta-lactam resistance among Escherichia coli strains isolated from urinary tract infections. Infez Med. 2016;24(4):326-30. [PubMed: 28011969].
  • 11. Asgharzadeh Kangachar S, Mojtahedi A. Evaluation of integrons classes 1–3 in extended spectrum beta-lactamases and multi drug resistant Escherichia coli isolates in the North of Iran. Gene Reports. 2018;12:299-303. doi: 10.1016/j.genrep.2018.07.014.
  • 12. Wayne P. Performance standards for antimicrobial susceptibility testing. 26th ed. Clinical and Laboratory Standards Institute (CLSI); 2016.
  • 13. Ruiz J. Mechanisms of resistance to quinolones: target alterations, decreased accumulation and DNA gyrase protection. J Antimicrob Chemother. 2003;51(5):1109-17. doi: 10.1093/jac/dkg222. [PubMed: 12697644].
  • 14. Soltani B, Heidari H, Ebrahim-Saraie HS, Hadi N, Mardaneh J, Motamedifar M. Molecular characteristics of multiple and extensive drug-resistant Acinetobacter baumannii isolates obtained from hospitalized patients in Southwestern Iran. Infez Med. 2018;26(1):67-76. [PubMed: 29525800].
  • 15. Tavakoly T, Jamali S, Mojtahedi A, Khan Mirzaei M, Shenagari M. The prevalence of CMY-2, OXA-48 and KPC-2 genes in clinical isolates of Klebsiella spp. Cell Mol Biol (Noisy-le-grand). 2018;64(3):40-4. doi: 10.14715/cmb/2018.64.3.7. [PubMed: 29506629].
  • 16. Haghighatpanah M, Mozaffari Nejad AS, Mojtahedi A, Amirmozafari N, Zeighami H. Detection of extended-spectrum beta-lactamase (ESBL) and plasmid-borne blaCTX-M and blaTEM genes among clinical strains of Escherichia coli isolated from patients in the north of Iran. J Glob Antimicrob Resist. 2016;7:110-3. doi: 10.1016/j.jgar.2016.08.005. [PubMed: 27721192].
  • 17. Ghaffarian F, Hedayati M, Sedigh Ebrahim-Saraie H, Atrkar Roushan Z, Mojtahedi A. Molecular epidemiology of ESBL-producing Klebsiella pneumoniae isolates in intensive care units of a tertiary care hospital, North of Iran. Cell Mol Biol (Noisy-le-grand). 2018;64(7):75-9. [PubMed: 29974849].
  • 18. Mansory Jamshidi N, Pakzad E, Tabaraee B, Hadadi A. Frequency of qnr genes in Escherichia coli strains resistant to quinolones isolated from Ilam Imam khomani hospital and Tehran Milad hospital. J Ilam Univ Med Sci. 2013;21(6):16-22.
  • 19. Alos JI, Serrano MG, Gomez-Garces JL, Perianes J. Antibiotic resistance of Escherichia coli from community-acquired urinary tract infections in relation to demographic and clinical data. Clin Microbiol Infect. 2005;11(3):199-203. doi: 10.1111/j.1469-0691.2004.01057.x. [PubMed: 15715717].
  • 20. Moreno E, Prats G, Sabate M, Perez T, Johnson JR, Andreu A. Quinolone, fluoroquinolone and trimethoprim/sulfamethoxazole resistance in relation to virulence determinants and phylogenetic background among uropathogenic Escherichia coli. J Antimicrob Chemother. 2006;57(2):204-11. doi: 10.1093/jac/dki468. [PubMed: 16390858].
  • 21. Alshara M. Antimicrobial resistant pattern of Escherichia coli strains isolated from pediatric patients in Jordan. Acta Med Iran. 2011;49(5):293-5. [PubMed: 21713746].
  • 22. Nakhaei Moghadam M, Moshrefi S. Determining the antibiotic resistance pattern of urinary isolates of Escherichia coli and prevalence of extended spectrum β-lactamases (ESBLs) among them. J Sabzevar Univ Med Sci. 2010;16(4):228-33.
  • 23. Niranjan V, Malini A. Antimicrobial resistance pattern in Escherichia coli causing urinary tract infection among inpatients. Indian J Med Res. 2014;139(6):945-8. [PubMed: 25109731]. [PubMed Central: PMC4165009].
  • 24. Castanheira M, Pereira AS, Nicoletti AG, Pignatari AC, Barth AL, Gales AC. First report of plasmid-mediated qnrA1 in a ciprofloxacin-resistant Escherichia coli strain in Latin America. Antimicrob Agents Chemother. 2007;51(4):1527-9. doi: 10.1128/AAC.00780-06. [PubMed: 17220425]. [PubMed Central: PMC1855464].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments